8DI4

Discovery of MK-8189, a highly potent and selective PDE10A inhibitor for the treatment of schizophrenia

Summary for 8DI4

Entry DOI	10.2210/pdb8di4/pdb
Descriptor	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, ZINC ION, MAGNESIUM ION, ... (5 entities in total)
Functional Keywords	pde10a, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological source	Homo sapiens (human)
Total number of polymer chains	2
Total formula weight	80157.25
Authors	Hayes, R.P.,Yan, Y. (deposition date: 2022-06-28, release date: 2023-02-08, Last modification date: 2023-10-25)
Primary citation	Layton, M.E.,Kern, J.C.,Hartingh, T.J.,Shipe, W.D.,Raheem, I.,Kandebo, M.,Hayes, R.P.,Huszar, S.,Eddins, D.,Ma, B.,Fuerst, J.,Wollenberg, G.K.,Li, J.,Fritzen, J.,McGaughey, G.B.,Uslaner, J.M.,Smith, S.M.,Coleman, P.J.,Cox, C.D. Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia. J.Med.Chem., 66:1157-1171, 2023 Cited by PubMed: 36624931 DOI: 10.1021/acs.jmedchem.2c01521 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.016 Å)

Structure validation